Editorial Comment from Dr Miyata and Dr Sakai to Sulfoquinovosylacylpropanediol is a novel potent radiosensitizer in prostate cancer

Int J Urol. 2015 Jun;22(6):597. doi: 10.1111/iju.12776. Epub 2015 Apr 23.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Blood Vessels / radiation effects*
  • Glycolipids / administration & dosage*
  • Humans
  • Male
  • Neovascularization, Pathologic / radiotherapy*
  • Prostatic Neoplasms / blood supply*
  • Prostatic Neoplasms / radiotherapy*
  • Radiation-Sensitizing Agents / administration & dosage*

Substances

  • Glycolipids
  • Radiation-Sensitizing Agents
  • sulfoquinovosylacylpropanediol